Supriya Life Sciences Q3 Results 2025:Supriya Life Sciences declared their Q3 results on 24 Jan, 2025, revealing impressive financial performance for the quarter. The company reported a topline increase of 32.54% year-on-year, with profits soaring by 57.03%. The profit for the quarter stood at ₹46.78 crore, while revenue reached ₹185.65 crore.
Despite the strong year-on-year growth, the company faced challenges compared to the previous quarter, where revenue and profit saw declines of 43.18% and 48.47%, respectively. Notably, Selling, General & Administrative expenses decreased by 50.29% quarter-over-quarter but increased by 12.59% year-on-year.
The operating income also experienced a downturn, decreasing by 48.25% quarter-over-quarter but showing an increase of 62.51% year-over-year. The Earnings Per Share (EPS) for Q3 was reported at ₹5.82, marking a 57.3% increase compared to the same quarter last year.
Supriya Life Sciences has delivered a 9.47% return over the last week and an impressive 90.62% return over the past six months, although it reported a slight decline of -1.28% Year-to-Date.
As of 25 Jan, 2025, Supriya Life Sciences boasts a market capitalization of ₹5,878.06 crore, with a 52-week high of ₹835.2 and a low of ₹288.9. Analysts remain optimistic, with 1 out of 1 covering analysts giving the stock a ‘Strong Buy’ rating.
The consensus recommendation as of 25 Jan, 2025, is to Strong Buy, indicating confidence in the company’s future performance and growth potential.
Supriya Life Sciences Financials
| Period | Q3 (FY25) | Q2 (FY25) | Q-o-Q Growth | Q3 (FY24) | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 185.65 | 326.73 | -43.18% | 140.07 | +32.54% |
| Selling/ General/ Admin Expenses Total | 19.77 | 39.77 | -50.29% | 17.56 | +12.59% |
| Depreciation/ Amortization | 4.96 | 9.4 | -47.23% | 3.96 | +25.25% |
| Total Operating Expense | 124.66 | 208.87 | -40.32% | 102.55 | +21.56% |
| Operating Income | 60.99 | 117.86 | -48.25% | 37.53 | +62.51% |
| Net Income Before Taxes | 62.58 | 121.84 | -48.64% | 40.1 | +56.06% |
| Net Income | 46.78 | 90.79 | -48.47% | 29.79 | +57.03% |
| Diluted Normalized EPS | 5.82 | 11.28 | -48.4% | 3.7 | +57.3% |
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.
#Supriya #Life #Sciences #Results #Jan #profit #rise #YOY #profit #crore #revenue #crore #Company #Business #News
Supriya Life Sciences Q3 result, Supriya Life Sciences, Supriya Life Sciences Q3, Supriya Life Sciences Quarterly Result, Q3 Result
latest news today, news today, breaking news, latest news today, english news, internet news, top news, oxbig, oxbig news, oxbig news network, oxbig news today, news by oxbig, oxbig media, oxbig network, oxbig news media
HINDI NEWS
News Source
